Generic AI training can introduce the tool, but it can’t change the work. That distinction matters for pharmaceutical organizations trying to move AI beyond curiosity, pilots, and isolated productivity wins.
A one-hour enterprise training may explain what generative AI is, how prompting works, or which tools are approved. But it rarely answers the question that determines whether adoption actually happens: What does this mean for my job on any given morning?
The Problem with Generic AI Training
Despite significant AI investment, Deloitte found that 37% of organizations are still using AI at a surface level, with little or no change to existing processes.1 That gap often appears when teams are trained on the technology, but not on how to apply it in their day-to-day work.
AI literacy is important. Teams need to understand what AI can and can’t do, how Large Language Models (LLMs) behave, and where human review remains essential, especially because AI can generate confident but inaccurate, incomplete, or unsupported outputs. More than 50% of leaders ranked AI literacy and applied AI skills as their top skills priority for 2026.2
But literacy is only the starting point. An MSL and a Regional Account Director may work in the same pharma organization, but they don’t make the same decisions, manage the same risks, or move work through the same approval paths. So why would they use the same AI playbook?
Awareness tells people AI exists. Role-specific enablement shows them where it belongs. Yet only 25% of leaders prioritized role-specific technical or functional skills in the same study, even though those are the skills that determine whether AI becomes part of daily work.2
Different Roles Need Different Use Cases
AI adoption only works when it reflects how people actually work. The following roles may all benefit from AI, but they need different prompts, inputs, review steps, and guardrails.
- MSL: Scientific literature synthesis, medical exchange preparation, congress insight organization, or field observation theme identification
- Regional Account Director: Account dynamic analysis, access barrier summaries, leadership update preparation, payer trend identification, or regional opportunity prioritization
- Field Consultant: Pre-call planning, post-call documentation, territory summaries, or follow-up preparation
- Medical Writer: Content structuring, source material comparison, or internal draft preparation
- Regulatory Coordinator: Dependency organization, document status tracking, or gap identification before submission
- Leadership Teams: Business review summaries, faster roll-ups, or field pattern visibility
From Prompt Templates to Workflow Guidance
A generic prompt library can give teams a false sense of readiness. It may include prompts for summarizing, drafting, brainstorming, or analyzing, but those prompts rarely reflect the regulated environment in which pharma teams operate. They often don’t clarify which data can be used, which tools are approved, which outputs are internal-only, or where human review is required.
Workflow guidance goes further. It helps users understand:
- What task the prompt supports
- What information can safely be entered
- Which tool or environment is appropriate
- What the output can and can’t be used for
- What needs to be reviewed before work moves forward
- How the prompt should change based on the role, audience, or business need
Without that context, prompts become another training artifact people forget to use. With it, they become a bridge between AI literacy and daily behavior.
Adoption Happens When the Work Feels Recognizable
Time is already constrained in pharma, and the people who could benefit most from AI are often the least likely to spend extra time experimenting. Field teams are traveling, medical and regulatory teams are reviewing materials, and commercial leaders are balancing launch priorities and performance pressure. AI adoption often stalls when the time and effort required to learn it outweigh the value of the time it saves.
That’s why generic demos fall flat. Translating them into a specific role, workflow, and regulated environment requires judgment, boundaries, and confidence. Role-specific enablement removes that burden by making training immediately relevant to the work people already do.
For training to drive adoption, it should reflect:
- Medical workflows: Scientific exchange preparation, insight synthesis, and appropriate internal use cases
- Commercial workflows: Account planning, access barriers, regional performance, and stakeholder communication
- Field workflows: Pre-call preparation, territory prioritization, documentation, and follow-up
- Medical writing and regulatory workflows: Content preparation, version control, submission dependencies, source alignment, and review readiness
- Leadership workflows: Decision quality, reporting consistency, risk visibility, and team-level capability building
One of the clearest signs of effective AI enablement is whether someone can use what they learned immediately in the flow of real work. Not someday. Not after they become an AI expert. Not after they figure out how to adapt a generic training module. Immediately.
From Training Event to Enablement System
Effective enablement needs a structure that helps teams practice, apply, and reinforce AI in the context of their actual work. That structure often includes:
- Role-based workshops and applied exercises that translate AI concepts into realistic workflows, scenarios, and decision points for each team
- Manager coaching and leadership modeling that help managers reinforce approved behaviors, ask better questions, and connect AI use to business priorities
- Internal champions and peer learning that create trusted points of contact, surface practical examples, and keep momentum moving after formal training ends
- Use-case libraries and prompt guidance that show where AI fits, what information can be used, what outputs require review, and how prompts should change by role or task
- Office hours and self-service resources that give teams a place to troubleshoot, build confidence, and return to clear guidance when questions come up
The Real Adoption Question
The question pharma leaders should be asking isn’t, “Have our teams been trained on AI?” The better question is, “Can each role use AI safely and confidently in the moments where it’d actually improve their work?”
Generic training may produce enthusiasm and a spike in experimentation, but role-specific enablement is what turns AI awareness into confident, compliant adoption. That distinction will define which pharma organizations scale AI successfully and which remain stuck in pilot mode.
CMK Select helps life sciences and pharmaceutical organizations design AI enablement programs grounded in role-specific workflows, so people can work smarter, adopt AI with confidence, and drive meaningful business impact. Connect with our team to build a program that fits the way your organization actually works.
Sources: